212 related articles for article (PubMed ID: 12189383)
61. [Radiation therapy and host immunity in malignant tumors (author's transl)].
Makidono A; Makidono R
Rinsho Hoshasen; 1978 Aug; 23(8):849-57. PubMed ID: 357791
[No Abstract] [Full Text] [Related]
62. Tumour immunology: the end of the beginning.
Hall JG
Practitioner; 1982 Dec; 226(1374):2010-20. PubMed ID: 7170295
[No Abstract] [Full Text] [Related]
63. Radiation-enhanced immune response to cancer: workshop, Anaheim, CA, April 17, 2005.
Sutherland RM
Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):3-5. PubMed ID: 16377408
[No Abstract] [Full Text] [Related]
64. Immunology of the cancer patient.
Med J Aust; 1973 Mar; 1(13):622-3. PubMed ID: 4540805
[No Abstract] [Full Text] [Related]
65. In-vivo detection of tumours and metastases with (monoclonal) antibodies.
Haisma H
Neth J Med; 1985; 28(3):108-11. PubMed ID: 3982570
[No Abstract] [Full Text] [Related]
66. Tumor-specific T-cell immunity: ready for prime time?
Greenberg PD; Riddell SR
J Natl Cancer Inst; 1992 Jul; 84(14):1059-61. PubMed ID: 1619675
[No Abstract] [Full Text] [Related]
67. [Breakdown of immunological surveillance].
Hosokawa M
Nihon Rinsho; 1986 Feb; 44(2):305-10. PubMed ID: 3517409
[No Abstract] [Full Text] [Related]
68. Immunity and cancer.
Barg S; Levin M; Rezzonico R
Int Adv Surg Oncol; 1981; 4():337-47. PubMed ID: 7251176
[No Abstract] [Full Text] [Related]
69. Pathobiology of lymphocyte interactions.
Sherwin RP; Richters A
Pathol Annu; 1973; 8():379-406. PubMed ID: 4583017
[No Abstract] [Full Text] [Related]
70. Tumor immunology: an overview.
Hellström I; Hellström KE
Ann N Y Acad Sci; 1993 Aug; 690():24-33. PubMed ID: 8368741
[No Abstract] [Full Text] [Related]
71. Suppression of cell-mediated immunity due to immune deviation.
Zhang Y
Chin Med J (Engl); 1996 Oct; 109(10):739-42. PubMed ID: 9275346
[No Abstract] [Full Text] [Related]
72. Safety concerns blight promising cancer therapy.
Ledford H
Nature; 2016 Oct; 538(7624):150-151. PubMed ID: 27734893
[No Abstract] [Full Text] [Related]
73. Introduction: methodology for detection of antigens in preneoplastic and neoplastic tissues.
Borsos T
Natl Cancer Inst Monogr; 1972 Dec; 35():3-4. PubMed ID: 4659053
[No Abstract] [Full Text] [Related]
74. [Stimulation of immunity in cancer patients by corynebacteria].
Israel L
Sem Hop Ther; 1974 Feb; 50(2):159-61. PubMed ID: 4548215
[No Abstract] [Full Text] [Related]
75. Peripheral blood of patients with cutaneous T-cell lymphoma: studies using monoclonal antibodies.
Berger CL; Edelson RL
J Cutan Pathol; 1983 Dec; 10(6):467-78. PubMed ID: 6363475
[No Abstract] [Full Text] [Related]
76. [The cancer-immunity relation].
Sáiz García F; Rodríqez Valverde V; Agüero Balbín R
Rev Clin Esp; 1982 Feb; 164(4):219-23. PubMed ID: 7089344
[No Abstract] [Full Text] [Related]
77. [Cellular immunity].
Mackaness GB
Med Lab (Stuttg); 1976 Apr; 29(4):71-8. PubMed ID: 1085409
[No Abstract] [Full Text] [Related]
78. Cellular immunotherapy in haematological malignancies.
Reid CD
Br J Haematol; 1999 Apr; 105 Suppl 1():7-10. PubMed ID: 10330926
[No Abstract] [Full Text] [Related]
79. The genesis of tumours--mutation or abnormal differentiation?
Finckh ES
Med J Aust; 1974 Mar; 1(12):438-41. PubMed ID: 4830916
[No Abstract] [Full Text] [Related]
80. [Immunologic studies of various diseases with monoclonal antibody (OKT 3, 4, 8)].
Ninomiya M; Kagawa S; Horimi T; Yoshida E; Hiramatsu S
Rinsho Ketsueki; 1983 Jul; 24(7):965-8. PubMed ID: 6605434
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
